CBGA: the reaction that starts hemp's cannabinoid series

10 entries on the CBGA record

The reaction behind the first acid

By the mid-1990s, cannabinoid chemistry was already well documented. Structures, names, analytical methods: all of that existed on paper. The open question sat further upstream. Which single reaction starts the whole series inside a living plant?

Fellermeier and Zenk published the answer in 1998 [1]. Their material was a transferase from hemp, an enzyme whose job is to move a chemical group from one molecule onto another. The starting compound was olivetolate, the working form of olivetolic acid, a small phenolic acid the plant assembles itself. The enzyme added a prenyl group, a short branched hydrocarbon unit. What came out was cannabigerolic acid. CBGA. In the same paper it is identified as the precursor of tetrahydrocannabinol [1].

Two features matter more than the vocabulary. The reaction is specific: one enzyme, one starting compound, one product. And it is reproducible, which is what separates a mapped step from a plausible proposal [1]. Since 1998, the origin of CBGA has been settled ground.

That is also why CBGA gets described as a starting point rather than a minor cannabinoid. In the plant, the acid comes first. The neutral forms most people recognise by name appear later, once the plant's own enzymes, and then heat and time, have done their work [2].

What decides which acid comes next

CBGA is a branch point. From there the route splits into three acid lines, and which line runs depends on the synthase enzymes the cultivar carries [1]. A synthase is an enzyme that builds one specific product. Carry one complement and the plant fills up with one acid. Carry another and the balance shifts.

So the ratio is not decided in the extraction hall. It is decided in the seed. Legal hemp in the EU is bred and selected to stay inside the THC limits that apply to the crop, rather than corrected once the plant is already grown. Two things follow from that. Cultivar choice is the first quality decision anyone makes, long before a press or a solvent enters the picture. And the cannabinoid profile printed on a batch report is largely a genetic fingerprint, confirmed by measurement rather than produced by it.

Dozens of cannabinoids, hundreds of other constituents

Put CBGA next to the full inventory and it stops looking exotic. In their 2005 review, ElSohly and Slade read cannabis as a complex mixture of natural cannabinoids, with dozens of individual cannabinoids catalogued alongside hundreds of other plant constituents [2].

That count surprises people, so it helps to know how the list gets long. Three kinds of entry do most of the work [2]. Acid and neutral forms of the same molecule are counted separately. Side-chain variants get their own line. Products that form as plant material ages are catalogued as well [2].

The acid form is what the plant actually makes. CBGA, THCA, CBDA: the A is the marker. Take the acid group away, usually through heat or long storage, and you have CBG, THC, CBD instead. Same skeleton, different molecule, separate entry [2]. It is the reason a batch analysis can carry two lines for what a shopper thinks of as one compound.

Side-chain variants follow the same logic. Hemp cannabinoids carry a hydrocarbon tail hanging off the ring system, and the plant does not always build that tail to the same length. Change the length and the molecule earns a different name and its own line in the catalogue, even though the rest of the structure is unchanged [2].

Ageing products are the third group. Plant material sitting in light, warmth and air changes over time, and some of what analysis finds in older material was not there at harvest [2]. A long catalogue is a record of everything identified across many samples. It is not a description of one jar.

CBGA holds one line in that inventory, but a particular one. Its position is upstream, documented as a single enzyme step from olivetolic acid [1], and the split downstream into three acid lines depends on the enzymes a given plant carries [1]. Dozens of names, one starting reaction. That is a fair short summary of what the two papers show together [1][2].

One caution about counting. Presence in a catalogue is not an amount in a bottle. The 2005 review documents what has been identified in the plant across the literature [2]. A batch analysis documents what one method measured in one batch. Both are useful. They answer different questions, and mixing them up is where most confusion about cannabinoid lists begins.

CBGA outside the plant

Transient, variable, and hard to isolate

The file on CBGA inside the plant is solid. The file outside it is much thinner, and the reasons are practical rather than mysterious.

Start with timing. CBGA turns up transiently, because the plant's own synthases keep pulling it along the three acid routes [1]. Then quantity. Amounts vary, plant to plant and stage to stage. Then processing. Under typical extraction and storage conditions, CBGA loses its acid group and becomes CBG, the neutral partner, which is exactly the acid-to-neutral pattern the 2005 catalogue records across cannabinoid pairs [2]. Put those three together and holding a stable quantity of CBGA becomes difficult work.

Which explains the shape of the published record. What 1998 established is the origin of the molecule [1]. Cannabinoid chemistry around it was already well documented before then, so the gap that closed was a biosynthetic one, not an analytical one. Questions about CBGA as a finished, isolated compound have far less behind them. For a good number of them, we don't know yet is the accurate answer, and it is the one we give.

Since 2014, the same rule for every cannabinoid

Cibdol has worked with cannabinoids since 2014, back when CBD still needed explaining at every dinner table. The rule we apply to CBGA is the rule we apply to all of them: state what the analysis shows, name where the information comes from, and leave the gaps visible instead of filling them with confident-sounding language.

In practice that comes down to three habits. Batch reports carry what the method measured, acid forms included where they belong to the profile, because acid and neutral versions are separate entries in the first place [2]. Cultivar choice comes before everything else, since the balance between acid lines is set by the synthase enzymes a plant carries [1], and European hemp is bred and selected within the THC limits for the crop rather than adjusted afterwards. And when a reader asks something the literature has not answered, the honest reply is that it has not been answered.

Swiss habits, mostly. Measure, record, publish, repeat. CBGA is a decent test of that approach, because it is the cannabinoid whose plant biochemistry is mapped in detail while its practical file stays short. Both are true at the same time. Printing both is the job.